InsidersTradesSigma
Moberg Pharma AB (publ) Stock: price and directors' dealings · Finland · FIN-FSA
Track the Moberg Pharma AB (publ) share price and the full insider trade history of the company, a listed issuer based in Finland. Shares are quoted on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, Moberg Pharma AB (publ) has recorded 9 public disclosures. Market capitalisation: €445.9m. The latest transaction was filed on 7 July 2026 (Purchase). Among the most active insiders: Lars Johansson. All data is free.
9
Insider Decl.
0
Thresholds
€85,582
9 ops.
Buy Volume
·
0 ops.
Sell Volume
29Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 7 July 2026
Declarations9 total
19,693 shares@ SEK 9.34AktieFI:csv-48a35a75d44de09d92c0
Ideal exit: 3 Apr 2027 (T+270)
10,000 shares@ SEK 10.690.0020% mcap50.0% of flowAktieFI:csv-202db981619a77b2e228
Ideal exit: 16 Feb 2027 (T+270)
10,000 shares@ €0.9770.0019% mcap100.0% of flowAktieFI:A003Y996-1
Ideal exit: 16 Feb 2027 (T+270)
4,711 shares@ €0.72890.0007% mcap100.0% of flowAktieFI:A003Q210-1
Ideal exit: 20 Mar 2026 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
35,851 shares@ €0.81810.0058% mcap100.0% of flowAktieFI:A003P585-1
Ideal exit: 2 Mar 2026 (T+270)
2,222 shares@ €0.82170.0004% mcap100.0% of flowAktieFI:A003P274-1
Ideal exit: 28 Feb 2026 (T+270)
2,490 shares@ SEK 6.4732.4% of flowBTU (betald tecknad unit)FI:A001P100-2
Ideal exit: 17 Sept 2021 (T+270)
5,250 shares@ SEK 6.4767.6% of flowBTU (betald tecknad unit)FI:A001O831-2
Ideal exit: 10 Sept 2021 (T+270)
15,500 shares@ SEK 6.47100.0% of flowBTU (betald tecknad unit)FI:A001P511-2
Ideal exit: 1 Oct 2021 (T+270)
9 of 9 declarations
About Moberg Pharma AB (publ)
Moberg Pharma AB (publ) is a Swedish pharmaceutical company focused on developing treatments for skin diseases. It is listed on the Stockholm Stock Exchange (XSTO).